CRP and depressive symptom measurement: Blood-samples were collected to assess peripheral immune markers (IL-6, CRP) and APOE-ε4 genotype.<h4>Results</h4>Objective cognitive impairment in at least one domain was present in 39% of the patients and 47% showed symptoms of moderate or severe depression.